Search





Search





Markets
/
Stocks
/
yi
/

111 Inc

Add to Watchlist

3.990USD

+0.190+5.00%

Close 07-23 16:00（ET）Quotes delayed by 15 min

207.36MMarket Cap

LossP/E TTM

111 Inc

3.990

+0.190+5.00%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

+5.00%

5 Days

+5.28%

1 Month

-6.99%

6 Months

-22.22%

Year to Date

+55.86%

1 Year

-45.71%

Key Figures

3.770Open

3.770High

196.00Volume

LossP/E TTM

--P/E Dynamic

--Dividend TTM

0.00%Turnover Ratio

3.800Prev. Close

3.770Low

406.00Turnover

LossP/E Static

-1.90P/B

0.00%Div Yield TTM

-0.90%ROA

11.17052wk High

0.04Volume Ratio

-64.74MNet Profit

51.97MShares

-0.1091EPS TTM

0.62Beta

--ROE

2.48052wk Low

0.00%Amplitude

5.33%Gross Margin

207.36MMarket Cap

-0.98Reward/Risk

5.33%Risk Rate

TradingKey Stock Score of 111 Inc

Currency: USD Updated: 2026-07-23

Key Insights

111 Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 108 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.In the medium term, the stock price is expected to trend down.Despite an average stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

111 Inc's Score

Industry at a Glance

Industry Ranking

108 / 155

Overall Ranking

304 / 4547

Industry

Pharmaceuticals

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Neutral

111 Inc Highlights

StrengthsRisks

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

Undervalued

The company’s latest PE is -35.93, at a low 3-year percentile range.

Held by James Simons

Star Investor James Simons holds 0.00 shares of this stock.